Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06642844 |
| Title | Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment (PHARBEVACOL) |
| Acronym | PHARBEVACOL |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | University Hospital, Tours |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | FRA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| BORG | RECRUITING | Besançon | France | Details | ||
| Caroline Petorin | NOT_YET_RECRUITING | Clermont-Ferrand | France | Details | ||
| Ducreux | NOT_YET_RECRUITING | Gustave Roussy | France | Details | ||
| David Tougeron | RECRUITING | Poitiers | France | Details |